Non-Compliance to Lymphatic Filariasis Preventive Chemotherapy and Associated Factors, Jawi District, Amhara Region, Northwest Ethiopia: Case Control Study

By Fetene, mihretu

dc.contributor.author	By Fetene, mihretu
dc.date.accessioned	2022-04-06T09:14:17Z
dc.date.available	2022-04-06T09:14:17Z
dc.date.issued	2021-06
dc.identifier.uri	http://ir.bdu.edu.et/handle/123456789/13417
dc.description.abstract	Introduction: Lymphatic Filariasis is a human disease caused by parasitic helminths mostly by Wuchereria bancrofti. To eliminate Lymphatic Filariasis, the World Health Organization recommends a combination of preventive chemotherapy using Ivermectin and Albendazole through mass drug administration. The mass drug administration is given annually to the entire population living in endemic areas irrespective of the individual infection status. In Jaw, after five rounds of drug distribution, the district failed in the Pre- Transmission Assessment Survey. This may be partially related to non-compliance of the annual mass drug administration treatment by the community members.	en_US
dc.language.iso	en	en_US
dc.subject	Ivermectin with albendazole, lymphatic filariasis, non-compliance, preventive chemotherapy	en_US
dc.title	Non-Compliance to Lymphatic Filariasis Preventive Chemotherapy and Associated Factors, Jawi District, Amhara Region, Northwest Ethiopia: Case Control Study	en_US
dc.type	Thesis	en_US